
HUP30
CAS No. 312747-21-0
HUP30( —— )
Catalog No. M37904 CAS No. 312747-21-0
HUP30 is a potent vasodilating agent. HUP30 can stimulate soluble guanylyl cyclase, activate K+ channels, and block extracellular Ca2+ influx.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 44 | Get Quote |
![]() ![]() |
10MG | 69 | Get Quote |
![]() ![]() |
25MG | 136 | Get Quote |
![]() ![]() |
50MG | 219 | Get Quote |
![]() ![]() |
100MG | 318 | Get Quote |
![]() ![]() |
200MG | 444 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameHUP30
-
NoteResearch use only, not for human use.
-
Brief DescriptionHUP30 is a potent vasodilating agent. HUP30 can stimulate soluble guanylyl cyclase, activate K+ channels, and block extracellular Ca2+ influx.
-
DescriptionHUP30 is a vasodilating agent. HUP30 stimulates soluble guanylyl cyclase, activate K+ channels, and blocks extracellular Ca2+ influx.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorCalcium Channel | Potassium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number312747-21-0
-
Formula Weight305.35
-
Molecular FormulaC14H15N3O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (327.49 mM; Ultrasonic (<50°C)
-
SMILES[O-][N+](=O)c1ccc2nc(NC(=O)C3CCCCC3)sc2c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Fusi F, et al. 2-Aryl- and 2-amido-benzothiazoles as multifunctional vasodilators on rat artery preparations. Eur J Pharmacol. 2013 Aug 15;714(1-3):178-87. ?
molnova catalog



related products
-
Fendiline hydrochlor...
Fendiline is a nonselective calcium channel blocker.
-
Vatanidipine
Vatanidipine (AE0047) is a novel dihydropyridine (DHP)-type calcium channel blocker with slow-onset pharmacological actions.
-
Yangambin
Yangambin is a selective antagonist of the cardiovascular effects of platelet activating factor (PAF); it has hypotensive effect, which is probably due to a peripheral vasodilatation that involves, at least, the inhibition the Ca2+ influx through voltage-gated Ca2+ channels. Yangambin has central nervous system activity, it presents a depressant activity in the open field, forced swimming and pentobarbital sleeping time tests.